Protein Summary
Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN (PubMed:18185537). Stabilizes and organizes elastic fibers in the skin, lung and vasculature (By similarity). Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling (PubMed:10428823). May act as an adapter that mediates the interaction between FBN1 and ELN (PubMed:17255108). The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in ...more
- ENST00000342058
- ENSP00000345008
- ENSG00000140092
- DANCE
- EVEC
- UP50
- ADCL2
- ARMD3
- DANCE
- ARCL1A
- FIBL-5
- HNARMD
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
viral protein | 1 | ||
protein domain | 0.92 | ||
virus perturbation | 0.9 | ||
virus | 0.89 | ||
disease | 0.75 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 213.69 (req: < 5)
Gene RIFs: 90 (req: <= 3)
Antibodies: 406 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 213.69 (req: >= 5)
Gene RIFs: 90 (req: > 3)
Antibodies: 406 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 12
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0